The evolving landscape of EUS utilization in the management of pancreatic cystic neoplasms
20 Feb 2025, 2 p.m.
Publication date: Available online 19 February 2025Source: PancreatologyAuthor(s): Daniel Marino, ...
Pancreatology Journal, latest articles
"Harnessing the Power of Organoids for Improved Outcomes in Pancreatic Cancer"
18 Feb 2025, 3 p.m.
Publication date: Available online 18 February 2025Source: PancreatologyAuthor(s): Laxmi Kirola, ...
From Misdiagnosis to Management Pancreatic Cystic Tumors Initially Identified as Pseudocysts Treated with Cystogastrostomy Experience form a Tertiary Center
16 Feb 2025, 10 a.m.
Publication date: Available online 16 February 2025Source: PancreatologyAuthor(s): Oğuzhan Şal, ...
Depth of response in patients with locally advanced pancreatic cancer treated with first-line chemotherapy: a supplementary analysis of JCOG1407
11 Feb 2025, 4 p.m.
Publication date: Available online 10 February 2025Source: PancreatologyAuthor(s): Taro Shibuki, ...
Evolving Trends in Interventions and Outcomes for Acute Biliary Pancreatitis During Pregnancy: A Two-Decade Analysis
11 Feb 2025, 4 p.m.
Publication date: Available online 10 February 2025Source: PancreatologyAuthor(s): Ayushi Jain, ...
Letter to the editor regarding “Early detection of pancreatic cancer: Study design and analytical considerations in biomarker discovery and early phase validation studies”
5 Feb 2025, 6 p.m.
Publication date: Available online 27 January 2025Source: PancreatologyAuthor(s): Stuart G. ...
Beyond 4 weeks? Rethinking the timing of LAMS removal in WOPN
5 Feb 2025, 6 p.m.
Publication date: Available online 29 January 2025Source: PancreatologyAuthor(s): Saswati Kar, ...
The efficacy and safety profile of third-line treatment in patients with metastatic pancreatic adenocarcinoma
5 Feb 2025, 6 p.m.
Publication date: Available online 1 February 2025Source: PancreatologyAuthor(s): Chi-Chen Lan, ...
News (September 2020)
COVIDSurg-Cancer paper accepted by JCO
14th Sep 2020
We are delighted to announce that COVIDSurg-Cancer paper accepted by JCO (impact factor 33), and would like to thank AUGIS/GBIHPBA for their support of the study. read more..